A groundbreaking study has shed light on the potential benefits of a triplet combination involving brentuximab vedotin (BV) for patients with diffuse large B-cell lymphoma (DLBCL). The study demonstrated that this combination therapy, consisting of BV, lenalidomide, and rituximab, led to significant improvements in overall survival (OS) compared to lenalidomide-rituximab alone in the third-line setting.
Carlo Ancelotti’s Real Madrid completed a remarkable feat by clinching their 15th Champions League title with a 2-0 victory over Borussia Dortmund at Wembley. This win, coupled with their LaLiga triumph, marked a perfect season for the club. Despite facing tough challenges and losing key players, Ancelotti’s side showcased resilience and determination on their path
The concept of the “Internet of Bodies” (IOB) is rapidly evolving, bridging the gap between technological devices and the human body. According to academic and author Andrea M. Matwyshyn, the IOB refers to a network of human bodies that rely on internet and related technologies for their integrity and functionality. As we move forward, the